Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib versus paclitaxel in relapsed urothelial tumors
ISRCTN73030316Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- May 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial in transitional cell carcinoma (TCC) comparing Pazopanib with Paclitaxel (2 arms). Primary endpoint: Overall survival. Started May 2012; status: completed.
02
Drugs
pazopanibpaclitaxel
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on ISRCTN73030316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73030316.